OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...

Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.

Impact Link Over the years, OpenAI CEO Sam Altman has shared predictions about where he thinks we're headed on artificial general intelligence, superintelligence, agentic AI, and more — and when ...

Sam Altman has shut down online "hype" after rumors ... Rumors that the company had achieved AGI, defined as a type of AI capable of understanding, learning, and performing any intellectual ...

Sam Altman, CEO of OpenAI ... stating AGI is expected by 2025. Altman envisions AI agents significantly impacting the workforce in the near future. “twitter hype is out of control again.